Factors associated with the consumption of chlorine dioxide to prevent and treat COVID-19 in the Peruvian population: a cross-sectional study

Abstract Background Chlorine dioxide has been promoted as an alternative for the prevention and treatment of COVID-19, especially in Peru, despite the lack of evidence to support its efficacy. This study aimed to evaluate the factors associated with chlorine dioxide consumption in the Peruvian popul...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	David R. Soriano-Moreno, Daniel Fernandez-Guzman, Fabricio Ccami-Bernal, Cristhian Rojas-Miliano, Wendy Nieto-Gutierrez
Formato:	article
Lenguaje:	EN
Publicado:	BMC 2021
Materias:	COVID-19 SARS-CoV-2 Pandemic Associated factors Chlorine dioxide (source: MESH) Public aspects of medicine RA1-1270
Acceso en línea:	https://doaj.org/article/88b45d0e7766458b900b01c67738e134
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:88b45d0e7766458b900b01c67738e134
record_format	dspace
spelling	oai:doaj.org-article:88b45d0e7766458b900b01c67738e1342021-11-21T12:11:07ZFactors associated with the consumption of chlorine dioxide to prevent and treat COVID-19 in the Peruvian population: a cross-sectional study10.1186/s12889-021-12191-91471-2458https://doaj.org/article/88b45d0e7766458b900b01c67738e1342021-11-01T00:00:00Zhttps://doi.org/10.1186/s12889-021-12191-9https://doaj.org/toc/1471-2458Abstract Background Chlorine dioxide has been promoted as an alternative for the prevention and treatment of COVID-19, especially in Peru, despite the lack of evidence to support its efficacy. This study aimed to evaluate the factors associated with chlorine dioxide consumption in the Peruvian population. Methods Analytical cross-sectional study. An adult Peruvian population was evaluated where chlorine dioxide consumption was divided into two groups according to the purpose of use: as prevention (individuals without COVID-19 history) and as treatment (individuals with COVID-19 history). The associated factors in each group were evaluated using Poisson regressions with the bootstrapping resampling method. Results Of 3610 participants included, 3213 reported no history of COVID-19, and 397 had been infected. The prevalence of chlorine dioxide consumption to prevent or treat COVID-19 was 8 and 16%, respectively. Factors either positively or negatively associated with chlorine dioxide consumption for prevention were male sex (aPR: 1.36; 95% CI: 1.09–1.71), being an adult or older adult (aPR: 0.54; 95% CI: 0.35–0.82), having a health sciences student within the family unit (aPR: 1.38; 95% CI: 1.02–1.87), using medical information as the main source of information of COVID-19 (aPR: 0.57; 95% CI: 0.40–0.80), having comorbidities for COVID-19 (aPR: 1.36; 95% CI: 1.01–1.82), considering COVID-19 dangerous and deadly (aPR: 0.57; 95% CI: 0.45–0.74), using medications (aPR: 1.59; 95% CI: 1.25–2.06) and plants to prevent COVID-19 (aPR: 1.69; 95% CI: 1.21–2.36), considering chlorine dioxide ineffective (aPR: 0.18; 95% CI: 0.18–0.24), and being uninformed of its efficacy (aPR: 0.21; 95% CI: 0.16–0.28). In addition, factors associated with chlorine dioxide consumption for treatment were considering COVID-19 dangerous and deadly (aPR: 0.56; 95% CI: 0.33–0.96), considering chlorine dioxide ineffective (aPR: 0.22; 95% CI: 0.12–0.42), and being uninformed of its efficacy (aPR: 0.15; 95% CI: 0.07–0.32). Conclusions The prevalence of chlorine dioxide consumption to treat COVID-19 was higher than prevent. It is important to apply information strategies, prioritizing population groups with certain characteristics that are associated with a higher consumption pattern.David R. Soriano-MorenoDaniel Fernandez-GuzmanFabricio Ccami-BernalCristhian Rojas-MilianoWendy Nieto-GutierrezBMCarticleCOVID-19SARS-CoV-2PandemicAssociated factorsChlorine dioxide (source: MESH)Public aspects of medicineRA1-1270ENBMC Public Health, Vol 21, Iss 1, Pp 1-10 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	COVID-19 SARS-CoV-2 Pandemic Associated factors Chlorine dioxide (source: MESH) Public aspects of medicine RA1-1270
spellingShingle	COVID-19 SARS-CoV-2 Pandemic Associated factors Chlorine dioxide (source: MESH) Public aspects of medicine RA1-1270 David R. Soriano-Moreno Daniel Fernandez-Guzman Fabricio Ccami-Bernal Cristhian Rojas-Miliano Wendy Nieto-Gutierrez Factors associated with the consumption of chlorine dioxide to prevent and treat COVID-19 in the Peruvian population: a cross-sectional study
description	Abstract Background Chlorine dioxide has been promoted as an alternative for the prevention and treatment of COVID-19, especially in Peru, despite the lack of evidence to support its efficacy. This study aimed to evaluate the factors associated with chlorine dioxide consumption in the Peruvian population. Methods Analytical cross-sectional study. An adult Peruvian population was evaluated where chlorine dioxide consumption was divided into two groups according to the purpose of use: as prevention (individuals without COVID-19 history) and as treatment (individuals with COVID-19 history). The associated factors in each group were evaluated using Poisson regressions with the bootstrapping resampling method. Results Of 3610 participants included, 3213 reported no history of COVID-19, and 397 had been infected. The prevalence of chlorine dioxide consumption to prevent or treat COVID-19 was 8 and 16%, respectively. Factors either positively or negatively associated with chlorine dioxide consumption for prevention were male sex (aPR: 1.36; 95% CI: 1.09–1.71), being an adult or older adult (aPR: 0.54; 95% CI: 0.35–0.82), having a health sciences student within the family unit (aPR: 1.38; 95% CI: 1.02–1.87), using medical information as the main source of information of COVID-19 (aPR: 0.57; 95% CI: 0.40–0.80), having comorbidities for COVID-19 (aPR: 1.36; 95% CI: 1.01–1.82), considering COVID-19 dangerous and deadly (aPR: 0.57; 95% CI: 0.45–0.74), using medications (aPR: 1.59; 95% CI: 1.25–2.06) and plants to prevent COVID-19 (aPR: 1.69; 95% CI: 1.21–2.36), considering chlorine dioxide ineffective (aPR: 0.18; 95% CI: 0.18–0.24), and being uninformed of its efficacy (aPR: 0.21; 95% CI: 0.16–0.28). In addition, factors associated with chlorine dioxide consumption for treatment were considering COVID-19 dangerous and deadly (aPR: 0.56; 95% CI: 0.33–0.96), considering chlorine dioxide ineffective (aPR: 0.22; 95% CI: 0.12–0.42), and being uninformed of its efficacy (aPR: 0.15; 95% CI: 0.07–0.32). Conclusions The prevalence of chlorine dioxide consumption to treat COVID-19 was higher than prevent. It is important to apply information strategies, prioritizing population groups with certain characteristics that are associated with a higher consumption pattern.
format	article
author	David R. Soriano-Moreno Daniel Fernandez-Guzman Fabricio Ccami-Bernal Cristhian Rojas-Miliano Wendy Nieto-Gutierrez
author_facet	David R. Soriano-Moreno Daniel Fernandez-Guzman Fabricio Ccami-Bernal Cristhian Rojas-Miliano Wendy Nieto-Gutierrez
author_sort	David R. Soriano-Moreno
title	Factors associated with the consumption of chlorine dioxide to prevent and treat COVID-19 in the Peruvian population: a cross-sectional study
title_short	Factors associated with the consumption of chlorine dioxide to prevent and treat COVID-19 in the Peruvian population: a cross-sectional study
title_full	Factors associated with the consumption of chlorine dioxide to prevent and treat COVID-19 in the Peruvian population: a cross-sectional study
title_fullStr	Factors associated with the consumption of chlorine dioxide to prevent and treat COVID-19 in the Peruvian population: a cross-sectional study
title_full_unstemmed	Factors associated with the consumption of chlorine dioxide to prevent and treat COVID-19 in the Peruvian population: a cross-sectional study
title_sort	factors associated with the consumption of chlorine dioxide to prevent and treat covid-19 in the peruvian population: a cross-sectional study
publisher	BMC
publishDate	2021
url	https://doaj.org/article/88b45d0e7766458b900b01c67738e134
work_keys_str_mv	AT davidrsorianomoreno factorsassociatedwiththeconsumptionofchlorinedioxidetopreventandtreatcovid19intheperuvianpopulationacrosssectionalstudy AT danielfernandezguzman factorsassociatedwiththeconsumptionofchlorinedioxidetopreventandtreatcovid19intheperuvianpopulationacrosssectionalstudy AT fabricioccamibernal factorsassociatedwiththeconsumptionofchlorinedioxidetopreventandtreatcovid19intheperuvianpopulationacrosssectionalstudy AT cristhianrojasmiliano factorsassociatedwiththeconsumptionofchlorinedioxidetopreventandtreatcovid19intheperuvianpopulationacrosssectionalstudy AT wendynietogutierrez factorsassociatedwiththeconsumptionofchlorinedioxidetopreventandtreatcovid19intheperuvianpopulationacrosssectionalstudy
_version_	1718419135203901440

Factors associated with the consumption of chlorine dioxide to prevent and treat COVID-19 in the Peruvian population: a cross-sectional study

Ejemplares similares